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Abstract 
Semisynthesis studies starting from (11Z)-I',2'-didehydrostemofoline indicated that the known Stemona 
alkaloid stemoburkilline is the Z-isomer and not the E-isomer as initially reported. The semisynthesis 
involved conversion of (11Z)-1',2' -didehydrostemofoline to II(S), 12(S)-dihydrostemofoline followed by a 
stereoselective base-catalyzed ring-opening reaction to give (Z)-stemoburkilline. The same product was 
obtained using a similar synthetic protocol stariing from isostemofoline via a based-catalyzed ring-
opening reaction of II (S), 12(R)-dihydrostemofoline. A re-examination of the crude root extracts of 
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Semisynthesis studies starting from (11Z)-I',2'-didehydrostemofoline (4) indicated that the known Stemona alkaloid 
stemoburkilline is the Z-isomer and not the E-isomer as initially reported. The semisynthesis involved conversion of 
(11Z)-1',2' -didehydrostemofoline (4) to II(S), 12(S)-dihydrostemofoline (3) followed by a stereoselective base-catalyzed 
ring-opening reaction to give (Z)-stemoburkilline (8). The same product was obtained using a similar synthetic protocol 
stariing from isostemofoline (6) via a based-catalyzed ring-opening reaction of II (S), 12(R)-dihydrostemofoline (1). A 
re-examination of the crude root extracts of Stel1lona burkillii Prain and further NOE studies established stemoburkilline 
as the Z-isomer (8). 
Reports increase steadily each year on the isolation and biological 
activities of the natural products arising from extracts of plants of 
Ste1710na species. Over 100 StemonCl alkaloids have been structurally 
characterized. I In 2004 we repOlied the isolation of two stemofoline 
alkaloids, 11 (S), 12(R)-dihydrostemofoline (1) and stemoburkilline 
(2), along with two known alkaloids from a root extract of Stemona 
burkillii Prain (Stemonaceae)? The structure and relative config-
uration of 1 were determined via interpretation of its spectroscopic 
data and from comparison with data from synthetic II(S),12(S)-
dihydrostemofoline (3). The configuration of the exo-cyclic alkene 
group in 2 was tentively assigned as E on the basis of mechanistic 
considerations. We had speculated that 2 arose from 1 via a ring-
opening reaction involving an elimination process. We report here 
the synthesis of 1 and 3 from (I1Z)-I',2'-didehydrostemofoline (4)3 
and their base-catalyzed ring-opening reactions to give (Z)-
stemoburkilline (8). A comparison of this synthetic compound (8) 
and the natural product found in the semipurified plant extracts 
(see Supporting Information) has allowed us to revise the structure 
of the natural product. 
Hydrogenation of (11Z)-1 ',2' -didehydrostemofoline (4) (isolated 
from the unidentified StemonCl species reported earlier)3 over Pd/C 
for I h gave stemofoline (5)4 in 96% yield (Scheme 1). Photolysis 
of a solution of 5 in chloroform, in the presence of acetophenone, 
for 7 h gave a mixture of 5 and its isomer, isostemofoline (6),5 in 
a ratio of approximately 9: 11. This mixture was separated by 
column chromatography (CC) to give 6 in 41 % yield and recovered 
5 in 33% yield (Scheme 1). Controlled hydrogenation of 5 and 6 
proved difficult and resulted in mixtures of the desired compounds 
3 and 1, respectively, plus the known over-reduced compound 7.6 .7 
The spectroscopic data of 1 and 3 were identical to those reported 
previously.2 
Treatment of a solution of 3 with DBU (2 equiv) resulted in a 
37:39:24 mixture of 1, 3, and 8, respectively, that was difficult to 
separate (Scheme 2). These products most likely arise from 
interconversion reactions via a reversible base-catalyzed ring-
opening of 3 and a reversible Michael addition reaction of the 
desired product 8 and/or base-catalyzed epimerization reactions 
between 1 and 3. To circumvent this problem, we repeated the ring-
opening reaction on 3 in the presence of TMSCI (2 equiv) to trap 
the intermediate ring-opened alkoxide product. Under these condi-
tions clean formation of the TMS ether of 8 (9) was realized from 
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MS analysis of the crude reaction mixture. Removal of the TMS 
ether of 9 under acidic conditions then provided a pure sample of 
8 in 61 % yield after purification by Cc. Under similar conditions 
compound 1 was converted to 8 in 69% yield (Scheme 2). The IH 
NMR spectrum of 8 was similar to that of stemoburkilline, which 
we had isolated earlier, but was not identical. The largest difference 
was observed for the chemical shift for H-9a, which occurred at 6 
3.28 in 8 and was reported to be at 6 3.60 in the natural product. 2 
An examination of the original IH NMR spectra of the original 
partially purified extracts of Stell10nCl burkillii showed compounds 
1, 3, and 8 to be present (42: 11:47, respectively; see Supporting 
Information). In this mixture a signal at 6 3.32 was observed along 
with other resonances (e.g., 6 5.48 (d, 110.0 Hz, IH, H-ll) and 
4.30 (br s, IH, H-2)) that were consistent with those of compound 
8; however no signal was seen at a 3.60. UnfOliunately we do not 
have the original sample of stemoburkilline to rerun its IH NMR 
spectrum under identical conditions to that of 8. We re-examined 
the original crude extracts of S. burkillii that had been kept at -20 
°c for 4.5 years. Partial purification of this extract by CC showed 
compounds 1, 3, and 8 to be present from IH NMR analysis (36: 
22:42, respectively; see SuppOliing Information). In this mixture a 
signal was observed at a 3.27, along with those also corresponding 
to compound 8. With compound 8 in hand we determined it to be 
1O.102I1np800755p CCC: $40.75 © 2009 American Chemical Society and American Society of Pharmacognosy 
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the Z-isomer on the basis of a NOE cross-peak between the furanone 
methoxy group and the alkene proton, We suspect that our original 
NMR sample of stemoburkilline may have had traces of HCl in 
the solution (the CDCl3 had not been base treated), resulting in a 
down field shift of H-9a, although other protons near the protonated 
nitrogen atom would have also been expected to be observed 
significantly more downfield if this were the case. On the basis of 
these considerations and from the results of our ring-opening 
reactions we now reassign the structure of stemoburkilline to that 
of 8, having the Z-configuration and not the E-configuration as we 
initially reported? It is quite possible that some of compounds 1, 
3, and 8 are artifacts, which have interconverted under nonenzymatic 
catalyzed reactions either in the plant or during the extractionl 
purification process. It has proven difficult however to analyze the 
crude extracts by NMR analysis to determine the ratio of these 
products due to their relative low abundance. 
The stereochemical outcome of the baselTMSCI-initiated ring-
opening reaction of 1 and 3 can be rationalized as occurring through 
an ElcB mechanism, as shown in Scheme 3. Deprotonation of 1 
or 3 by DBU at the acidic y-position of the lactone ring would 
result in the anionic intermediate A. TMSCI-assisted ring-opening 
would then give the Z-isomer 9. Ring-opening via the anionic 
intermediate B, which would lead to (E)-stemoburkilline, would 
be less likely due to an unfavorable steric interaction between the 
methoxy and methyl groups in this intermediate (Scheme 3), 











General Experimental Procedures. As described previously,2,3 IH 
NMR assignments were achieved with the aid of gCOSY and, in some 
cases, NOESY experiments. J3C NMR assignments were based upon 
DEPT, gHSQC, and gHMBC experiments, All compounds were 
homogeneous by TLC analysis and judged to be of >95% purity based 
upon IH NMR analysis. 
Plant Material. The known starting material, (lIZl-l',2'-didehy-
drostemofoline (4), was isolated from the unidentified Stell10na species 
that we reported earlier. 3 The roots of this Stell10na species were 
collected at Amphur Mae Moh, Lampang, Thailand, in November 2007. 
The plant material was identified by Mr. James Maxwell as the same 
species as we had previously studied.3 A voucher specimen, number 
25375, was deposited at the Herbarium of the Department of Biology, 
Chiang Mai University. 
Extraction and Isolation. The dry, ground root of the Stemona 
species (935 g) was extracted with 95% EtOH (4 x 3000 mL) over 4 
days at rt. The ethanolic solution was evaporated to give a dark brown 
residue (148 g). The extract was partitioned between MeOH/HzO 
(I: I) and CH2Ch. The organic extract was dried over MgS04 and 
concentrated in vacuo to give a dark brown residue (20 g). A portion 
of this material (500 mg) was chromatographed on silica gel (100 mL) 
with gradient elution from CHzCh to CH2Ch/MeOH/NHj (95:5: I) to 
give (lIZl-I',2'-didehydrostemofoline (4)3 as a yellow-brown gum 
(242.8 mg, 48% w/w). 
Stemofoline (5). To a solution of 4 (100.8 mg, 0.262 mmol) in 
EtOAc (4.0 mL) at rt was added Pd/C (10 mg, 10% w/w), and the 
flask was flushed with Nz for 10 min before the solution was left to 
stir under a Hz atmosphere for I h. The flask was flushed with N2 , and 
the solution was filtered through Celite and washed with EtOAc. The 
filtrate was dried over MgS04 and concentrated in vacuo to give 5 as 
a yellow-brown gum (98 mg, 0.253 mmol, 96% yield). The NMR data 
agreed with those reported for the natural product.4 
Isostemofoline (6). To a large NMR tube (5 mm diameter) 
containing a solution of 5 (48.3 mg, 0.125 mmol) in CHCb (2 mL) at 
rt was added acetophenone (50 pL). The mixture was irradiated with 
a 500 W lamp for 7 h to give a mixture of stemofoline (5) and 
isostemofoline (6) (ca. 9: II). The mixture was separated by CC using 
gradient elution from CHzCIz to CH2Clz/MeOHINH3 (95:5: I) as eluent 
to give 6 as a white, amorphous solid (20 mg, 0.052 mmol, 41 % yield) 
and 5 (15.8 mg, 0.041 mmol, 33% yield). The NMR data of 6 agreed 
with those reported for the natural product. 5 
11(S),12(R)-Dihydrostemofoline (1). To a solution of 6 (29.6 mg, 
0.076 mmol) in EtOH (3.0 mL) at rt was added Pd/C (3.0 mg, 10% 
w/w), and the flask was flushed with Nz for 10 min before the solution 
was left to stir under a Hz atmosphere for 24 h. The flask was flushed 
with Nz, and the solution was filtered through Celite and washed with 
MeOH. The filtrate was concentrated in vacuo, and the residue was 
purified by column chromatography using gradient elution from CH2Cl2 
to CH2C\z/MeOH/NH3 (95:5: I) to give 1 as a colorless gum (6.2 mg, 
0.016 mmol, 21 % yield) and the ring-open product 7 (8.9 mg, 0.023 
mmol, 30% yield) as a brown gum. The NMR data of 1 agreed with 
those reported for the natural product.2 
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1l(S),12(S)-Dihydrostemofoline (3). To a solution of 5 (83.1 mg, 
0.214 mmol) in EtOH (3.0 mL) at rt was added Pd/C (8.3 mg, 10% 
w/w), and the flask was flushed with Nz for 10 min before the solution 
was left to stir under a Hz atmosphere for 24 h. The flask was flushed 
with N2 , and the solution was filtered through Celite and washed with 
MeOH. The filtrate was concentrated in vaCllO, and the residue was 
pUlified by column chromatography using gradient elution from CH2Ch 
to CH2CliMeOHINH3 (95:5: I) to give 3 as a colorless gum (20.9 mg, 
0.054 mmol, 25% yield) and the ring-opened product 7 (13.5 mg, 0.035 
mmol, 16% yield, dr = 72:28) as a brown gum. The NMR data of 3 
agreed with that reported.2 The IH NMR data of the major diastereomer 
of 7 agreed with those supplied to us by Dr. Velton.6 .7 
Compound 7: Rf = 0.10 in MeOH/EtOAc (1:4); [a.m +6.3 
(c 0.65, CHCh); IH NMR [major diastereomer, 500 MHz, CDCh] 
04.72 (d, 1 8.0 Hz, IH, H-12); 4.28 (br s, IH, H-2); 4.05 (s, 3H, 
O-Me); 3.24 (br s, IH, H-9a); 3.02 (m, IH, H-5a); 2.93 (m, lH, 
H-5b); 2.48 (m, IH, H-Ila); 2.13 (m, lH, H-IO); 2.04 (d, 1 3.5 Hz, 
IH, H-7); 1.94 (s, 3H, H-16); 1.88 (m, IH, H-Ia); 1.85 (m, 2H, 
H-6a, H-6b); 1.66 (m, IH, H-9); 1.62 (m, IH, H-I b); 1.49 (m, 2H, 
H-I'a, H-l'b); 1.44 (m, IH, H-Ilb); 1.40 (m, IH, H-2'a); 1.33 (m, 
2H, H-3'a, H-3'b); 1.22 (m, IH, H-2'b); 1.00 (d, J 6.5 Hz, 3H, H-18); 
0.91 (t, J 7.5 Hz, 3H, H-4'); l3C NMR [125 MHz, CDCI3] 0 175.0 
(C-15); 174.6 (C-l3); 107.0 (C-8); 97.6 (C-14); 82.1 (C-3); 80.1 
(C-2); 78.1 (C-12); 63.5 (C-9a); 58.8 (O-CH3); 57.2 (C-7); 47.5 (C-
5); 43.6 (C-9); 40.8 (C-II); 34.3 (C-I); 31.8 (C-I'); 28.4 (C-IO); 
27.5 (C-2'); 26.6 (C-6); 23.3 (C-3'); 18.5 (C-17); 14.2 (C-4'); 8.3 
(C-16). Minor diastereomer: l3C NMR [125 MHz, CDCI3] 0 175.0 
(C-15); 174.3 (C-l3); 106.7 (C-8); 97.4 (C-14); 82.1 (C-3); 80.2 
(C-2); 76.6 (C-12); 63.7 (C-9a); 58.9 (O-CH3); 57.0 (C-7); 47.5 (C-
5); 43.3 (C-9); 40.2 (C-ll); 34.4 (C-I); 31.7 (C-l '); 28.4 (C-IO); 
27.2 (C-2'); 26.7 (C-6); 23.3 (C-3'); 17.8 (C-17); 14.2 (C-4'); 8.5 
(C-16); LRMS (ESI+) mlz 392.2 (100%) [MHj+, 393.2 (46%), 394.2 
(24%); HRMS (ESI+) mlz 392.2432 [MH]+, caled for CZZH34NOs 
392.2437. 
(Z)-Stemoburkilline (8). To a solution of 3 (20.9 mg, 0.054 mmol) 
in dry CH2Clz (0.5 mL) at rt under a Nz atmosphere were added DBU 
(16.0 pL, 0.107 mmol, 2.0 equiv) and TMSCI (13.7 pL, 0.107 mmol, 
2.0 equiv), and the reaction mixture was left to stir at rt for 15 h until 
the reaction was complete by TLC analysis. The mixture was then 
diluted with CH2Clz (10 mL), and the solution was washed with brine, 
dried over MgSO.j, and concentrated ill vacuo to give the TMS-protected 
product 9 as a dark brown gum (LRMS (El) /11lz 461 (M+', 100%)). 
The residue was dissolved in MeOH (1.5 mL), and then 10% wlv HCl 
(1.0 mL) was added and the solution was left to stir at rt under a N2 
atmosphere for 45 min. The solution was then evaporated under vacuum 
to give a white residue. A saturated NaHC03 solution (7 mL) was then 
added, and the mixture was extracted with CHzCIz (3 x 20 mL). The 
combined organic extracts were washed with brine and dried over 
MgS04 before being concentrated in vaCllO. The crude product was 
Notes 
purified by column chromatography using gradient elution from CH2Clz 
to CH2Clz/MeOHINH3 (95:5: I) to give (Z)-stemoburkilline (8) as a pale 
yellow, amorphous solid (12.9 mg, 0.033 mmol, 61 % yield for the 2 
steps): [a.lt,4 +7.6 (c 0.64, CHCh); IR Vma, (em-I); 3751, 2933,1750, 
1635,974,756; IH NMR [500 MHz, CDCU 0 5.48 (d, J 10.0 Hz, IH, 
H-Il); 4.30 (br s, IH, H-2); 4.10 (s, 3H, O-Me); 3.28 (br s, lH, H-9a); 
3.13 (m, IH, H-IO); 3.05 (m, IH, H-5a); 2.94 (m, IH, H-5b); 2.15 (d, 
J 5.0 Hz, lH, H-7); 2.05 (s, 3H, H-16); 1.91 (m, IH, H-Ia); 1.83 (m, 
2H, H-6a, H-6b); 1.74 (m, IH, H-9); 1.59 (m, JH, H-Ib); 1.48 (m, 2H, 
H-I'a, H-I'b); 1.38 (m, IH, H-2'a); 1.32 (m, 2H, H-3'); 1.24 (m, IH, 
H-2'b); 1.05 (d, J 6.5 Hz, 3H, H-17); 0.90 (t, 17.5 Hz, 3H, H-4'); l3c 
NMR [125 MHz, CDChl 0170.8 (C-15); 162.1 (C-l3); 142.1 (C-12); 
115.2 (C-II); 106.2 (C-8); 99.5 (C-14); 82.1 (C-3); 80.6 (C-2); 63.8 
(C-9a); 59.1 (O-CH3); 55.9 (C-7); 47.5 (C-5); 45.0 (C-9); 33.7(C-l); 
31.7 (C-I'); 28.6 (C-IO); 27.5 (C-2'); 26.7 (C-6); 23.4 (C-3'); 18.8 (C-
17); 14.2 (C-4'); 8.8 (C-16); LRMS (EI) /11lz 389 (33%) [M]+; HRMS 
(EI) /11lz 389.2213 [M]+, caled for C22H31NOs 389.2202. 
The title compound 8 was also prepared from 1 (18.7 mg, 0.048 
mmol) using the above procedure. The product was isolated as a pale 
yellow, amorphous solid (12.8 mg, 0.033 mmol, 69% yield for the 2 
steps). 
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